Advisory Committee
Business Development
Gene Saragnese
Former CEO of Phillip Imaging, and former GM of GE MRI
Gene Saragnese joined MaxQ Technology Ltd. in January 2016, as its Chairman & Chief Executive Officer. MaxQ is a company founded in deep learning and computer vision. MaxQ delivers patient-specific lifesaving diagnostic information directly to the physician at the patient’s bedside. In early 2020, he moved into the role of Vice Chairman at MaxQ.
Mr. Saragnese also served as the Chairman of the Board of Mirada Medical, a Healthcare SW company, and as the Independent director on the Insightec board. Before joining MaxQ, Mr. Saragnese served as the Philips Healthcare CEO of Philips Imaging Systems from April 2009 until May 2015.
As the Executive Vice President and CEO of Philips Imaging Systems, he led the company’s Imaging Systems business, a $7.5B enterprise, encompassing Advanced Diagnostic Imaging (Computed Tomography, Magnetic Resonance Imaging, and Molecular Imaging); Diagnostic X-Ray; Interventional and Ultrasound. He also directed Integrated Clinical Solutions which took a disease-focused approach to health care and included the radiation and interventional oncology business. He was responsible for 10,000 employees at sites in the United States, India, the Netherlands, Germany, Israel, China, and Brazil.
Before joining Philips, Mr. Saragnese served as GE Healthcare’s Vice President and General Manager of Molecular Resonance Imaging and Computed Tomography. In this capacity, he led a multi-billion-dollar business group, including Computed Tomography, Positron Emission Tomography (PET), Nuclear Imaging, PET Radiopharma, Preclinical Imaging and Image Post Processing. Prior to that, he served as Chief Technology Officer, Vice President of Global Technology for GE Healthcare. In this role, Mr. Saragnese led Global Product Development Engineering and Component Operations around the world, including Corporate Research sites in New York, China, India, and Germany. He has also served as General Manager Global Sourcing leading a global $6B procurement operation, General Manager for GE Medical Systems’ Global MRI business, and the leader for GE Medical Systems’ Global MRI Engineering organization.
Before his career in health care, Mr. Saragnese held management roles with GE, RCA, Martin Marietta, and Lockheed Martin in the aerospace industry. He is a graduate of Rutgers College of Engineering in New Jersey.
Allan Wong
Vtech Chairman and Founder
Allan Wong, Chairman of the Advisory Committee, is an Entrepreneur, the Co-Founder, Chairman, and CEO of VTech Group, Chairman of Innovation Technology Committee of Hong Kong, member of Institute of Applied Science and Technology, member of the Board of Trustees of the University of Hong Kong, Vice Chairman and Independent Non-Executive Director of Bank of East Asia, Independent Non-Executive Director of China-Hong Kong Photo Products Holdings Ltd., and Hong Kong Li & Fung.
Mr. Wong won the Chiang’s Science and Technology achievement award in 1999 and ranked 203 on the Forbes list of richest Chinese in 2015. Mr. Wong received a bachelor’s degree of Science in Electrical Engineering, University of Hong Kong, a master’s degree of Science in Electrical and Computer Engineering, University of Wisconsin, Madison, USA, and an Honorary Doctor of Science and Technology, Hong Kong University of Technology.
Frank Liu
Former MD of Transpac Capital
Frank Liu, Chairman of Chelmsford International Ltd since 2003. As a retired VC, Mr. Liu brings over 30 years of successful investment and M&A experiences including early-stage investments with outstanding exits such as Alibaba (1999), Hsu Fu Chi (1997), Want Want (1996), EMC (1995), ESS (1995), Ting Yi (1994), Neon-Neon (1994), etc.
Mr. Liu was the Advisor for the successful acquisition of 60% of Hsu Fu Chi by Nestlé (China) in 2011 for $1.7billion – at that time, the largest acquisition deal in the PRC for the non-banking sector. Mr. Liu is a founding Director of Taiwan M & A and Private Equity Council since 2009 and was a Director & EVP and member of Investment Committee of Transpac Capital Pte Ltd., past President of MIT Alumni Association of Taiwan.
Ravi Govindan
Founder of Mercatus Capital and former Group President of Fisher Scientific Asia Pacific
Armed with 45 years’ worth of real-world expertise in building companies from the ground up, Ravi Govindan founded Mercatus Capital in 2006, to nurture and invest in the next generation of start-up businesses. Mr. Govindan’s other successes range from growing his law practice into a multi-partnership firm to building properties across the Asia Pacific region, to being instrumental in the launches of several IPOs on the Australian and Singaporean stock exchanges.
Mr. Govindan was also the Executive Chairman and President of Fisher Scientific Inc. for the Asia Pacific region. Currently, Mr. Govindan — having taken a back seat to focus on his family and personal interests — is the Chairman Emeritus of Eight Mercatus, where his philanthropic support and expertise remain vital.
XinJun Liang
Co-founder and former CEO of Fusun Group
XinJun Liang was the Vice Chairman and Chief Executive Officer of Fosun Group from 1992 to 2017. Mr. Liang is also a member of the Private Equity Investment Fund Professional Committee of Asset Management Association of China, and the Chief Expert specializing in the investment of Insurance Association of China. Born in Zhejiang Province in 1968, he received a bachelor’s degree in Genetic Engineering in 1991 from Fudan University. Mr. Liang graduated with a master’s degree in business administration in 2007 from Cheung Kong Graduate School of Business and a doctorate in Business Administration (Global Financial Management) from Arizona State University in 2015.
Yulin Wei
Former Chairman and President of SinoPharma Holding
Yulin Wei is an MBA holder, a senior economist, and a qualified pharmacist. His career began at Tianjin Pharmaceutical Center from a position of a salesman and was promoted over the years (1984 to 1999) to Deputy General Manager before assuming the role of Executive Deputy General Manager, Pharmaceutical Company of Development Zone of the Pharmaceutical Department of Tianjin Pharmaceutical Center in the China Pharmaceutical Group.
From 1999 to 2003, Mr. Wei served as the general manager of Tianjin Company of China Pharmaceutical Group before moving on to be the Chief Operating Officer, Executive Deputy General Manager, President, and Chairman of Sinopharm Holding Co., Ltd.
Mr. Wei became the CEO of Sinopharm holding Medical Investment Management Co., Ltd. In 2017. He has won many awards and accolades from the Tianjin, China Pharmaceutical Group Corporation, the Ministry of Human Resources and Social Security of China, and the Shanghai Municipal government successively. One of his proudest accomplishments was winning the Best Business Leader Award of China in 2012 and elected as the best CEO of The Year; as well as The Most Respected Chairman of China’s Listed Companies and The Leader of International Multinational Companies in 2016. In 2019, Mr. Wei was elected as Outstanding Person in the 40th anniversary of Reform and Opening Up of China’s Pharmaceutical Circulation Industry.
Gene Saragnese
Former CEO of Phillip Imaging, and former GM of GE MRI
Gene Saragnese joined MaxQ Technology Ltd. in January 2016, as its Chairman & Chief Executive Officer. MaxQ is a company founded in deep learning and computer vision. MaxQ delivers patient-specific lifesaving diagnostic information directly to the physician at the patient’s bedside. In early 2020, he moved into the role of Vice Chairman at MaxQ.
Mr. Saragnese also served as the Chairman of the Board of Mirada Medical, a Healthcare SW company, and as the Independent director on the Insightec board. Before joining MaxQ, Mr. Saragnese served as the Philips Healthcare CEO of Philips Imaging Systems from April 2009 until May 2015.
As the Executive Vice President and CEO of Philips Imaging Systems, he led the company’s Imaging Systems business, a $7.5B enterprise, encompassing Advanced Diagnostic Imaging (Computed Tomography, Magnetic Resonance Imaging, and Molecular Imaging); Diagnostic X-Ray; Interventional and Ultrasound. He also directed Integrated Clinical Solutions which took a disease-focused approach to health care and included the radiation and interventional oncology business. He was responsible for 10,000 employees at sites in the United States, India, the Netherlands, Germany, Israel, China, and Brazil.
Before joining Philips, Mr. Saragnese served as GE Healthcare’s Vice President and General Manager of Molecular Resonance Imaging and Computed Tomography. In this capacity, he led a multi-billion-dollar business group, including Computed Tomography, Positron Emission Tomography (PET), Nuclear Imaging, PET Radiopharma, Preclinical Imaging and Image Post Processing. Prior to that, he served as Chief Technology Officer, Vice President of Global Technology for GE Healthcare. In this role, Mr. Saragnese led Global Product Development Engineering and Component Operations around the world, including Corporate Research sites in New York, China, India, and Germany. He has also served as General Manager Global Sourcing leading a global $6B procurement operation, General Manager for GE Medical Systems’ Global MRI business, and the leader for GE Medical Systems’ Global MRI Engineering organization.
Before his career in health care, Mr. Saragnese held management roles with GE, RCA, Martin Marietta, and Lockheed Martin in the aerospace industry. He is a graduate of Rutgers College of Engineering in New Jersey.
Allan Wong
Vtech Chairman and Founder
Allan Wong, Chairman of the Advisory Committee, is an Entrepreneur, the Co-Founder, Chairman, and CEO of VTech Group, Chairman of Innovation Technology Committee of Hong Kong, member of Institute of Applied Science and Technology, member of the Board of Trustees of the University of Hong Kong, Vice Chairman and Independent Non-Executive Director of Bank of East Asia, Independent Non-Executive Director of China-Hong Kong Photo Products Holdings Ltd., and Hong Kong Li & Fung.
Mr. Wong won the Chiang’s Science and Technology achievement award in 1999 and ranked 203 on the Forbes list of richest Chinese in 2015. Mr. Wong received a bachelor’s degree of Science in Electrical Engineering, University of Hong Kong, a master’s degree of Science in Electrical and Computer Engineering, University of Wisconsin, Madison, USA, and an Honorary Doctor of Science and Technology, Hong Kong University of Technology.
Frank Liu
Former MD of Transpac Capital
Frank Liu, Chairman of Chelmsford International Ltd since 2003. As a retired VC, Mr. Liu brings over 30 years of successful investment and M&A experiences including early-stage investments with outstanding exits such as Alibaba (1999), Hsu Fu Chi (1997), Want Want (1996), EMC (1995), ESS (1995), Ting Yi (1994), Neon-Neon (1994), etc.
Mr. Liu was the Advisor for the successful acquisition of 60% of Hsu Fu Chi by Nestlé (China) in 2011 for $1.7billion – at that time, the largest acquisition deal in the PRC for the non-banking sector. Mr. Liu is a founding Director of Taiwan M & A and Private Equity Council since 2009 and was a Director & EVP and member of Investment Committee of Transpac Capital Pte Ltd., past President of MIT Alumni Association of Taiwan.
Ravi Govindan
Founder of Mercatus Capital and former Group President of Fisher Scientific Asia Pacific
Armed with 45 years’ worth of real-world expertise in building companies from the ground up, Ravi Govindan founded Mercatus Capital in 2006, to nurture and invest in the next generation of start-up businesses. Mr. Govindan’s other successes range from growing his law practice into a multi-partnership firm to building properties across the Asia Pacific region, to being instrumental in the launches of several IPOs on the Australian and Singaporean stock exchanges.
Mr. Govindan was also the Executive Chairman and President of Fisher Scientific Inc. for the Asia Pacific region. Currently, Mr. Govindan — having taken a back seat to focus on his family and personal interests — is the Chairman Emeritus of Eight Mercatus, where his philanthropic support and expertise remain vital.
Co-founder and former CEO of Fusun Group
XinJun Liang was the Vice Chairman and Chief Executive Officer of Fosun Group from 1992 to 2017. Mr. Liang is also a member of the Private Equity Investment Fund Professional Committee of Asset Management Association of China, and the Chief Expert specializing in the investment of Insurance Association of China. Born in Zhejiang Province in 1968, he received a bachelor’s degree in Genetic Engineering in 1991 from Fudan University. Mr. Liang graduated with a master’s degree in business administration in 2007 from Cheung Kong Graduate School of Business and a doctorate in Business Administration (Global Financial Management) from Arizona State University in 2015.
Yulin Wei
Former Chairman and President of SinoPharma Holding
Yulin Wei is an MBA holder, a senior economist, and a qualified pharmacist. His career began at Tianjin Pharmaceutical Center from a position of a salesman and was promoted over the years (1984 to 1999) to Deputy General Manager before assuming the role of Executive Deputy General Manager, Pharmaceutical Company of Development Zone of the Pharmaceutical Department of Tianjin Pharmaceutical Center in the China Pharmaceutical Group.
From 1999 to 2003, Mr. Wei served as the general manager of Tianjin Company of China Pharmaceutical Group before moving on to be the Chief Operating Officer, Executive Deputy General Manager, President, and Chairman of Sinopharm Holding Co., Ltd.
Mr. Wei became the CEO of Sinopharm holding Medical Investment Management Co., Ltd. In 2017. He has won many awards and accolades from the Tianjin, China Pharmaceutical Group Corporation, the Ministry of Human Resources and Social Security of China, and the Shanghai Municipal government successively. One of his proudest accomplishments was winning the Best Business Leader Award of China in 2012 and elected as the best CEO of The Year; as well as The Most Respected Chairman of China’s Listed Companies and The Leader of International Multinational Companies in 2016. In 2019, Mr. Wei was elected as Outstanding Person in the 40th anniversary of Reform and Opening Up of China’s Pharmaceutical Circulation Industry.
Science Technology
Michael Harsh
Former CTO of GE Healthcare
Michael Harsh is a co-founder and Chief Product Officer of Terapede Systems, a digital X-ray start-up that focuses on developing an ultra-high resolution medical flat panel X-ray detector. He co-founded Terapede in 2015. Before Terapede, Mr. Harsh had a 36-year career with General Electric (GE). He held numerous positions within GE and served as Vice President and Chief Technology Officer of GE Healthcare, an $18 billion division of GE, where he led its global science and technology organization and research and development teams in diagnostics, healthcare IT, and life sciences. In 2004, Mike was named Global Technology Leader – Imaging Technologies at the GE Global Research Center, where he led the research for imaging technologies across the company as well as the research associated with computer visualization and superconducting systems.
Additionally, Mr. Harsh is a member of the boards of directors of, Compute Health (NYSE: CPUH-UN), Endra Life Sciences (NASDAQ: NDRA), Imagion Biosystems (IBX.AX), and EmOpti as well as being a member of the Radiological Society of North America (“RSNA”), Research & Education Foundation Board of Trustees. He had previously served as a director for FloDesign Sonics until its acquisition by MilliporeSigma, a division of the Merck Group. He is also a McKinsey Senior Advisor and a consultant in the medical device industry. Mr. Harsh is a graduate of Marquette University, where he earned a bachelor’s degree in Electrical Engineering. He holds numerous U.S. patents in the field of medical imaging and instrumentation. In 2008, Mr. Harsh was elected to the American Institute for Medical and Biological Engineering College of Fellows for his significant contributions to the medical and biological engineering field.
Member of CAE and former Head of EEE Department of University of Hong Kong
Prof. C. C. Chan holds BSc, MSc, Ph.D., HonDSc, HonDTech degrees. Honorary Professor and Former Head of the Department of Electrical and Electronic Engineering at the University of Hong Kong; Visiting Professor of MIT, University of Cambridge, etc; Prof. Chan is also the founding President of the World Electric Vehicle Association; Senior Consultant to governments, Strategic Adviser or Independent Director of public companies and industries; Fellow of the Royal Academy of Engineering, U.K., Chinese Academy of Engineering, IEEE, IET, and HKIE.
Former CEO of ASTRI Hong Kong and former Chairman of EE Department of Columbia University
Frank Liu, Chairman of Chelmsford International Ltd since 2003. As a retired VC, Mr. Liu brings over 30 years of successful investment and M&A experiences including early-stage investments with outstanding exits such as Alibaba (1999), Hsu Fu Chi (1997), Want Want (1996), EMC (1995), ESS (1995), Ting Yi (1994), Neon-Neon (1994), etc. Mr. Liu was the Advisor for the successful acquisition of 60% of Hsu Fu Chi by Nestlé (China) in 2011 for $1.7billion – at that time, the largest acquisition deal in the PRC for the non-banking sector. Mr. Liu is a founding Director of Taiwan M & A and Private Equity Council since 2009 and was a Director & EVP and member of Investment Committee of Transpac Capital Pte Ltd., past President of MIT Alumni Association of Taiwan.
Member of CAS and former President of University of Hong
Armed with 45 years’ worth of real-world expertise in building companies from the ground up, Ravi Govindan founded Mercatus Capital in 2006, to nurture and invest in the next generation of start-up businesses. Mr. Govindan’s other successes range from growing his law practice into a multi-partnership firm to building properties across the Asia Pacific region, to being instrumental in the launches of several IPOs on the Australian and Singaporean stock exchanges. Mr. Govindan was also the Executive Chairman and President of Fisher Scientific Inc. for the Asia Pacific region. Currently, Mr. Govindan — having taken a back seat to focus on his family and personal interests — is the Chairman Emeritus of Eight Mercatus, where his philanthropic support and expertise remain vital.
Member of CAS and former President of Fudan University
XinJun Liang was the Vice Chairman and Chief Executive Officer of Fosun Group from 1992 to 2017. Mr. Liang is also a member of the Private Equity Investment Fund Professional Committee of Asset Management Association of China, and the Chief Expert specializing in the investment of Insurance Association of China. Born in Zhejiang Province in 1968, he received a bachelor’s degree in Genetic Engineering in 1991 from Fudan University. Mr. Liang graduated with a master’s degree in business administration in 2007 from Cheung Kong Graduate School of Business and a doctorate in Business Administration (Global Financial Management) from Arizona State University in 2015.
Michael Harsh
Former CTO of GE Healthcare
Michael Harsh is a co-founder and Chief Product Officer of Terapede Systems, a digital X-ray start-up that focuses on developing an ultra-high resolution medical flat panel X-ray detector. He co-founded Terapede in 2015. Before Terapede, Mr. Harsh had a 36-year career with General Electric (GE). He held numerous positions within GE and served as Vice President and Chief Technology Officer of GE Healthcare, an $18 billion division of GE, where he led its global science and technology organization and research and development teams in diagnostics, healthcare IT, and life sciences. In 2004, Mike was named Global Technology Leader – Imaging Technologies at the GE Global Research Center, where he led the research for imaging technologies across the company as well as the research associated with computer visualization and superconducting systems.
Additionally, Mr. Harsh is a member of the boards of directors of, Compute Health (NYSE: CPUH-UN), Endra Life Sciences (NASDAQ: NDRA), Imagion Biosystems (IBX.AX), and EmOpti as well as being a member of the Radiological Society of North America (“RSNA”), Research & Education Foundation Board of Trustees. He had previously served as a director for FloDesign Sonics until its acquisition by MilliporeSigma, a division of the Merck Group. He is also a McKinsey Senior Advisor and a consultant in the medical device industry. Mr. Harsh is a graduate of Marquette University, where he earned a bachelor’s degree in Electrical Engineering. He holds numerous U.S. patents in the field of medical imaging and instrumentation. In 2008, Mr. Harsh was elected to the American Institute for Medical and Biological Engineering College of Fellows for his significant contributions to the medical and biological engineering field.
Professor C.C. Chan
Member of CAE and former Head of EEE Department of University of Hong Kong
Prof. C. C. Chan holds BSc, MSc, Ph.D., HonDSc, HonDTech degrees. Honorary Professor and Former Head of the Department of Electrical and Electronic Engineering at the University of Hong Kong; Visiting Professor of MIT, University of Cambridge, etc; Prof. Chan is also the founding President of the World Electric Vehicle Association; Senior Consultant to governments, Strategic Adviser or Independent Director of public companies and industries; Fellow of the Royal Academy of Engineering, U.K., Chinese Academy of Engineering, IEEE, IET, and HKIE.
Professor Edward Yang
Former CEO of ASTRI Hong Kong and former Chairman of EE Department of Columbia University
Professor Edward Yang received his education from National Cheng Kung (BSEE), Oklahoma State (MS), and Yale (Ph.D.) universities. After 3 years as a circuit designer at IBM, he spent his entire career at Columbia University serving as the EE Head between 1986 and 1996. He came to HKU in 1997 for a decade, founding the Jockey Club MRI Engineering Centre and e-Business Research Institute; also became a Founder, and later Director of SMIC of Shanghai. He spent 4 years at ASTRI, HK’s applied research institute, 2 as its CEO. He is currently Professor Emeritus at Columbia, Honorary Professor at HKU, and Visiting Scientist at Jinan University‘s GHM Institute of CNS Neuro-Regeneration. He is an IEEE Life Fellow.
Professor Patrick Cheng
Member of CAS and former President of University of Hong Kong
Professor Patrick Cheng conducted pioneering research work in MOS technology from the late ‘60s to ‘80s in Canada and HK and the Academician, Chinese Academy of Sciences. He was also the former President of the City University of Hong Kong and former VC at The University of Hong Kong. He is the Honorary Professor at the University of Electronic Science and Technology of China, City University of Hong Kong, South China University of Science and Technology.
Yuliang Yang
Member of CAS and former President of Fudan University
Yuliang Yang was born in Haiyan County, Zhejiang Province in November 1952.
He studied in the Department of chemistry of Fudan University from 1974 to 1977. In 1984, he obtained a Ph.D. degree in Chemistry (polymer chemistry and Physics) from Fudan University by his doctoral dissertation “graph theory of static and dynamic behaviors of polymer chain”.
Mr. Yang went to the German Max-Planck Institute of Polymer Research worked as a postdoc from 1986 to 1988. The research topic in that period focused on the development of solid-state NMR research methods for polymeric condensed states. He became the Professor of Polymer Science of Fudan University in 1993. He was elected academician of Chinese Academy of Sciences in 2003; and served as Vice President of Fudan University from 1999 to 2006, responsible for scientific research and transformation of scientific research results.
Mr. Yang went to Beijing to serve as the Director of the Office of the Degree Committee, State Council from 2006 to 2009. He returned to Shanghai where he was appointed as the President of Fudan University and assumed that role from 2009 to 2014. Mr. Yang next became the Director of the Institute for Preservation and Conservation of Chinese Ancient Books, Fudan University. Since 2015, he was also appointed as the Director of the Science Education and Popularization Committee of the Chinese Academy of Sciences.